Cite Filings / ALDX / 0001928391-24-000002

Feed Companies Filings Check

Sign in

144

Sale of Securities

Aldeyra Therapeutics, Inc. Filed 2024-08-12 Acc 0001928391-24-000002

Documents 1

144 Sale of Securities , xsl144X01/primary_doc.xml

Around this filing

2025-08-12 144 Sale of Securities
2024-08-14 4 Chief Development Officer sold 16,041 shares at $4.74 ($75,975)
2024-08-14 4 See Remarks sold 10,834 shares at $4.74 ($51,313)
2024-08-12 144 Sale of Securities
2024-08-12 144 Sale of Securities
2024-08-08 8-K Regulation FD disclosure · Other events

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…